RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 86 filers reported holding RUBIUS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,966,000 | +249.2% | 74,200 | 0.0% | 0.00% | – |
| Q4 2020 | $563,000 | +48.5% | 74,200 | -2.0% | 0.00% | – |
| Q3 2020 | $379,000 | -12.7% | 75,700 | +4.4% | 0.00% | – |
| Q2 2020 | $434,000 | +42.8% | 72,500 | +6.1% | 0.00% | – |
| Q1 2020 | $304,000 | -57.2% | 68,300 | -8.8% | 0.00% | -100.0% |
| Q4 2019 | $711,000 | +77.8% | 74,887 | +46.8% | 0.00% | – |
| Q3 2019 | $400,000 | -39.5% | 51,000 | +21.4% | 0.00% | -100.0% |
| Q2 2019 | $661,000 | -70.3% | 42,000 | -65.9% | 0.00% | -66.7% |
| Q1 2019 | $2,226,000 | +11.0% | 123,000 | -1.4% | 0.00% | 0.0% |
| Q4 2018 | $2,006,000 | – | 124,777 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
| Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
| Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
| HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
| Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
| Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
| Caption Management, LLC | 86,000 | $652,000 | 0.02% |
| Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |